Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

263 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Curative therapy for rectal cancer.
Alawawdeh A, Krishnan T, Roy A, Karapetis C, Joshi R, Singhal N, Price T. Alawawdeh A, et al. Among authors: karapetis c. Expert Rev Anticancer Ther. 2021 Feb;21(2):193-203. doi: 10.1080/14737140.2021.1845145. Epub 2021 Jan 8. Expert Rev Anticancer Ther. 2021. PMID: 33161803 Review.
Management of small cell lung cancer.
Yip D, Karapetis C, Steer C. Yip D, et al. Among authors: karapetis c. Expert Rev Anticancer Ther. 2001 Aug;1(2):197-210. doi: 10.1586/14737140.1.2.197. Expert Rev Anticancer Ther. 2001. PMID: 12113025 Review.
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.
Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, Bechstein WO, Primrose JN, Walpole ET, Finch-Jones M, Jaeck D, Mirza D, Parks RW, Collette L, Praet M, Bethe U, Van Cutsem E, Scheithauer W, Gruenberger T; EORTC Gastro-Intestinal Tract Cancer Group; Cancer Research UK; Arbeitsgruppe Lebermetastasen und-tumoren in der Chirurgischen Arbeitsgemeinschaft Onkologie (ALM-CAO); Australasian Gastro-Intestinal Trials Group (AGITG); Fédération Francophone de Cancérologie Digestive (FFCD). Nordlinger B, et al. Lancet. 2008 Mar 22;371(9617):1007-16. doi: 10.1016/S0140-6736(08)60455-9. Lancet. 2008. PMID: 18358928 Free PMC article. Clinical Trial.
K-ras mutations and benefit from cetuximab in advanced colorectal cancer.
Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ, Zalcberg JR. Karapetis CS, et al. N Engl J Med. 2008 Oct 23;359(17):1757-65. doi: 10.1056/NEJMoa0804385. N Engl J Med. 2008. PMID: 18946061 Free article. Clinical Trial.
Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008.
Price TJ, Tebbutt NC, Karapetis CS, Segelov E, Pavlakis N, Cunningham D, Sobrero AF, Haller DG, Shapiro JD. Price TJ, et al. Among authors: karapetis cs. Clin Colorectal Cancer. 2010 Jan;9(1):8-14. doi: 10.3816/CCC.2010.n.001. Clin Colorectal Cancer. 2010. PMID: 20100683 Review.
Epidemiology of neuroendocrine cancers in an Australian population.
Luke C, Price T, Townsend A, Karapetis C, Kotasek D, Singhal N, Tracey E, Roder D. Luke C, et al. Among authors: karapetis c. Cancer Causes Control. 2010 Jun;21(6):931-8. doi: 10.1007/s10552-010-9519-4. Epub 2010 Apr 24. Cancer Causes Control. 2010. PMID: 20419344
263 results